{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:06:48Z","timestamp":1762459608414,"version":"3.41.0"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","award":["564-0053"],"award-info":[{"award-number":["564-0053"]}],"id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbr.2018.05.005","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T01:59:44Z","timestamp":1527127184000},"page":"31-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine-induced deficits in cognitive function and social interaction"],"prefix":"10.1016","volume":"350","author":[{"given":"L.","family":"Rajagopal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.Y.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2018.05.005_bib0005","first-page":"1","article-title":"Neurosteroids: of the nervous system, by the nervous system, for the nervous system","volume":"52","author":"Baulieu","year":"1997","journal-title":"Recent Prog. Horm. Res."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neubiorev.2012.10.005","article-title":"Neurosteroids, stress and depression: potential therapeutic opportunities","volume":"37","author":"Zorumski","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2018.05.005_bib0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuroscience.2011.06.076","article-title":"Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence","volume":"191","author":"Marx","year":"2011","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.bbr.2018.05.005_bib0020","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/npp.2009.26","article-title":"Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia","volume":"34","author":"Marx","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.bbr.2018.05.005_bib0025","doi-asserted-by":"crossref","first-page":"12012","DOI":"10.3390\/molecules181012012","article-title":"Pregnenolone sulfate: from steroid metabolite to TRP channel ligand","volume":"18","author":"Harteneck","year":"2013","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0006-8993(99)01381-5","article-title":"Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites","volume":"830","author":"Park-Chung","year":"1999","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.bbr.2018.05.005_bib0035","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1124\/mol.52.6.1113","article-title":"Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids","volume":"52","author":"Park-Chung","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbr.2018.05.005_bib0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","article-title":"Neurosteroids: endogenous role in the human brain and therapeutic potentials","volume":"186","author":"Reddy","year":"2010","journal-title":"Prog. Brain Res."},{"issue":"17","key":"10.1016\/j.bbr.2018.05.005_bib0045","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1007\/s00213-014-3643-x","article-title":"Pregnenolone sulfate as a modulator of synaptic plasticity","volume":"231","author":"Smith","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.bbr.2018.05.005_bib0050","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1248\/bpb.26.709","article-title":"Studies on neurosteroids XVI. Levels of pregnenolone sulfate in rat brains determined by enzyme-linked immunosorbent assay not requiring solvolysis","volume":"26","author":"Higashi","year":"2003","journal-title":"Biol. Pharm. Bull."},{"issue":"24","key":"10.1016\/j.bbr.2018.05.005_bib0055","doi-asserted-by":"crossref","first-page":"14033","DOI":"10.1073\/pnas.241503698","article-title":"The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: distinct mechanisms?","volume":"98","author":"Akwa","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(99)01964-2","article-title":"Pregnenolone sulfate increases hippocampal acetylcholine release and spatial recognition","volume":"852","author":"Darnaudery","year":"2000","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.bbr.2018.05.005_bib0065","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1073\/pnas.89.5.1567","article-title":"Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it","volume":"89","author":"Flood","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"10.1016\/j.bbr.2018.05.005_bib0070","doi-asserted-by":"crossref","first-page":"10806","DOI":"10.1073\/pnas.92.23.10806","article-title":"Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive","volume":"92","author":"Flood","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0006-8993(00)01953-3","article-title":"Prolonged intracerebroventricular infusion of neurosteroids affects cognitive performances in the mouse","volume":"858","author":"Ladurelle","year":"2000","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/hbeh.2001.1677","article-title":"Pregnenolone sulfate and aging of cognitive functions: behavioral, neurochemical, and morphological investigations","volume":"40","author":"Mayo","year":"2001","journal-title":"Horm. Behav."},{"issue":"26","key":"10.1016\/j.bbr.2018.05.005_bib0085","doi-asserted-by":"crossref","first-page":"14865","DOI":"10.1073\/pnas.94.26.14865","article-title":"Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus","volume":"94","author":"Vallee","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2018.05.005_bib0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbr.2013.10.026","article-title":"Pregnenolone sulphate enhances spatial orientation and object discrimination in adult male rats: evidence from a behavioural and electrophysiological study","volume":"258","author":"Plescia","year":"2014","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.bbr.2018.05.005_bib0095","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2826.2008.01727.x","article-title":"Steroid receptor signalling in the brain--lessons learned from molecular imaging","volume":"20","author":"Kawata","year":"2008","journal-title":"J. Neuroendocrinol."},{"issue":"4-5","key":"10.1016\/j.bbr.2018.05.005_bib0100","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neuint.2007.08.022","article-title":"Pregnenolone sulfate in the brain: a controversial neurosteroid","volume":"52","author":"Schumacher","year":"2008","journal-title":"Neurochem. Int."},{"issue":"1-2","key":"10.1016\/j.bbr.2018.05.005_bib0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0006-8993(87)91394-1","article-title":"Pregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain?","volume":"404","author":"Majewska","year":"1987","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0110","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0006-8993(89)90024-3","article-title":"Pregnenolone sulfate antagonizes GABAA receptor-mediated currents via a reduction of channel opening frequency","volume":"489","author":"Mienville","year":"1989","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pharmthera.2007.03.011","article-title":"Neurosteroid binding sites on GABA(a) receptors","volume":"116","author":"Hosie","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bbr.2018.05.005_bib0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-011-2593-9","article-title":"Negative modulation of GABAA alpha5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats","volume":"221","author":"Redrobe","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-010-2039-9","article-title":"Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia","volume":"214","author":"Damgaard","year":"2011","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.yhbeh.2014.05.005","article-title":"The neurosteroid allopregnanolone impairs object memory and contextual fear memory in male C57BL\/6J mice","volume":"66","author":"Rabinowitz","year":"2014","journal-title":"Horm. Behav."},{"key":"10.1016\/j.bbr.2018.05.005_bib0135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbr.2016.03.019","article-title":"Neurosteroid allopregnanolone attenuates cognitive dysfunctions in 6-OHDA-induced rat model of Parkinson\u2019s disease","volume":"305","author":"Nezhadi","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"10","key":"10.1016\/j.bbr.2018.05.005_bib0140","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.biopsych.2016.05.022","article-title":"Layer 3 excitatory and inhibitory circuitry in the prefrontal cortex: developmental trajectories and alterations in schizophrenia","volume":"81","author":"Hoftman","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2018.05.005_bib0145","doi-asserted-by":"crossref","first-page":"16778","DOI":"10.1038\/srep16778","article-title":"Parvalbumin-positive interneurons of the prefrontal cortex support working memory and cognitive flexibility","volume":"5","author":"Murray","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/archpsyc.64.2.156","article-title":"Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia","volume":"64","author":"Menzies","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2018.05.005_bib0155","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuropharm.2015.04.012","article-title":"Subchronic phencyclidine treatment in adult mice increases GABAergic transmission and LTP threshold in the hippocampus","volume":"100","author":"Nomura","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2018.05.005_bib0160","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-3-642-25758-2_10","article-title":"Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications","volume":"213","author":"Coyle","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbr.2018.05.005_bib0165","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s002130051049","article-title":"Interactive effects of subanesthetic ketamine and haloperidol in healthy humans","volume":"145","author":"Krystal","year":"1999","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.bbr.2018.05.005_bib0175","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1017\/S1461145713000928","article-title":"Translating the N-methyl-d-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia","volume":"16","author":"Meltzer","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.bbr.2018.05.005_bib0180","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1046\/j.1471-4159.1998.71052018.x","article-title":"The neurosteroid pregnenolone sulfate increases cortical acetylcholine release: a microdialysis study in freely moving rats","volume":"71","author":"Darnaudery","year":"1998","journal-title":"J. Neurochem."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2018.05.005_bib0185","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0006-8993(93)91524-V","article-title":"Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat","volume":"607","author":"Mayo","year":"1993","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.bbr.2018.05.005_bib0190","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0306-4522(98)00174-2","article-title":"The neurosteroid pregnenolone sulfate infused into the nucleus basalis increases both acetylcholine release in the frontal cortex or amygdala and spatial memory","volume":"87","author":"Pallares","year":"1998","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.bbr.2018.05.005_bib0195","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02247383","article-title":"The neurosteroid pregnenolone sulfate reduces learning deficits induced by scopolamine and has promnestic effects in mice performing an appetitive learning task","volume":"126","author":"Meziane","year":"1996","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2018.05.005_bib0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0074-7742(01)46066-1","article-title":"Neurosteroids in learning and memory processes","volume":"46","author":"Vallee","year":"2001","journal-title":"Int. Rev. Neurobiol."},{"issue":"3","key":"10.1016\/j.bbr.2018.05.005_bib0205","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1124\/jpet.108.143958","article-title":"Nanomolar concentrations of pregnenolone sulfate enhance striatal dopamine overflow in vivo","volume":"327","author":"Sadri-Vakili","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0210","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1471-4159.2008.05627.x","article-title":"Pregnenolone sulfate induces NMDA receptor dependent release of dopamine from synaptic terminals in the striatum","volume":"107","author":"Whittaker","year":"2008","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.bbr.2018.05.005_bib0215","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1176\/appi.ajp.2015.15030338","article-title":"Attention must be paid: the association of plasma Clozapine\/NDMC ratio with working memory","volume":"172","author":"Meltzer","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"1-2","key":"10.1016\/j.bbr.2018.05.005_bib0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-004-1940-5","article-title":"The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine","volume":"177","author":"Weiner","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2018.05.005_bib0225","article-title":"Add-on pregnenolone with L-Theanine to antipsychotic therapy relieves negative and anxiety symptoms of schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial","author":"Kardashev","year":"2015","journal-title":"Clin. Schizophr Relat. Psychoses"},{"issue":"4","key":"10.1016\/j.bbr.2018.05.005_bib0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3371\/CSRP.KRBA.013114","article-title":"Adjunctive pregnenolone ameliorates the cognitive deficits in recent-onset schizophrenia: an 8-Week, randomized, double-blind, placebo-controlled trial","volume":"10","author":"Kreinin","year":"2018","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"6","key":"10.1016\/j.bbr.2018.05.005_bib0235","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/pcn.12150","article-title":"Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: an 8-week, double-blind, randomized add-on two-center trial","volume":"68","author":"Ritsner","year":"2014","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"10","key":"10.1016\/j.bbr.2018.05.005_bib0240","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.4088\/JCP.09m05031yel","article-title":"Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial","volume":"71","author":"Ritsner","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbr.2018.05.005_bib0245","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuroscience.2011.04.017","article-title":"The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia","volume":"191","author":"Ritsner","year":"2011","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.bbr.2018.05.005_bib0250","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1530\/eje.0.1420466","article-title":"Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from alzheimer\u2019s disease and vascular dementia","volume":"142","author":"Bernardi","year":"2000","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"10.1016\/j.bbr.2018.05.005_bib0255","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.biopsych.2006.06.017","article-title":"The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer\u2019s disease","volume":"60","author":"Marx","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"11","key":"10.1016\/j.bbr.2018.05.005_bib0260","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1210\/jc.2002-020878","article-title":"Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients","volume":"87","author":"Weill-Engerer","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bbr.2018.05.005_bib0265","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0006-3223(94)91139-8","article-title":"CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI","volume":"35","author":"George","year":"1994","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbr.2018.05.005_bib0270","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.155.7.910","article-title":"Effects of antidepressant treatment on neuroactive steroids in major depression","volume":"155","author":"Romeo","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbr.2018.05.005_bib0275","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","article-title":"Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine","volume":"95","author":"Uzunova","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.005_bib0280","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1176\/appi.ajp.2009.08121873","article-title":"Roles of the Akt\/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action","volume":"167","author":"Freyberg","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0285","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00213-011-2561-4","article-title":"The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats","volume":"221","author":"Horiguchi","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2018.05.005_bib0290","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbr.2015.08.040","article-title":"Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism","volume":"301","author":"Horiguchi","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.bbr.2018.05.005_bib0295","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/jnc.12512","article-title":"Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism","volume":"128","author":"Huang","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2018.05.005_bib0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0079-6123(08)00909-6","article-title":"In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems","volume":"172","author":"Meltzer","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.005_bib0305","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/0269881117693746","article-title":"Dopamine D4 receptor stimulation contributes to novel object recognition: relevance to cognitive impairment in schizophrenia","volume":"31","author":"Miyauchi","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2018.05.005_bib0310","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbr.2015.10.044","article-title":"Nicotinic receptors and lurasidone-mediated reversal of phencyclidine-induced deficit in novel object recognition","volume":"301","author":"Miyauchi","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.05.005_bib0315","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2015.10.060","article-title":"GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice","volume":"299","author":"Rajagopal","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.05.005_bib0320","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbr.2017.02.036","article-title":"RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia","volume":"332","author":"Rajagopal","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.005_bib0325","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-015-4137-1","article-title":"Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice","volume":"233","author":"Rajagopal","year":"2016","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.bbr.2018.05.005_bib0330","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/FBP.0b013e32833fa7df","article-title":"Current pharmacological models of social withdrawal in rats: relevance to schizophrenia","volume":"21","author":"Gururajan","year":"2010","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0335","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.euroneuro.2015.11.016","article-title":"Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology","volume":"26","author":"Neill","year":"2016","journal-title":"Eur Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0340","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0893-133X(97)00200-5","article-title":"Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats","volume":"19","author":"Sams-Dodd","year":"1998","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.bbr.2018.05.005_bib0345","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s002130050060","article-title":"Modification of behavioral effects of drugs in mice by neuroactive steroids","volume":"148","author":"Ungard","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.bbr.2018.05.005_bib0350","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1046\/j.1460-9568.1999.00858.x","article-title":"Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat","volume":"11","author":"Millan","year":"1999","journal-title":"Eur J. Neurosci."},{"issue":"31","key":"10.1016\/j.bbr.2018.05.005_bib0355","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.2174\/1381612819666131216114240","article-title":"The novel object recognition test in rodents in relation to cognitive impairment in schizophrenia","volume":"20","author":"Rajagopal","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0360","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1734-1140(10)70265-6","article-title":"Pregnenolone sulfate infused in lateral septum of male rats impairs novel object recognition memory","volume":"62","author":"Nanfaro","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbr.2018.05.005_bib0365","article-title":"NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update","author":"Cadinu","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2018.05.005_bib0370","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/7854_2015_403","article-title":"Postnatal phencyclidine (PCP) as a neurodevelopmental animal model of schizophrenia pathophysiology and symptomatology: a review","volume":"29","author":"Grayson","year":"2016","journal-title":"Curr. Topics Behavioral Neurosciences"},{"issue":"1-2","key":"10.1016\/j.bbr.2018.05.005_bib0375","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0006-8993(98)00085-7","article-title":"The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice","volume":"791","author":"Reddy","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2018.05.005_bib0380","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroscience.2016.03.021","article-title":"The neural basis of reversal learning: an updated perspective","volume":"345","author":"Izquierdo","year":"2017","journal-title":"Neuroscience"},{"issue":"27","key":"10.1016\/j.bbr.2018.05.005_bib0385","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1523\/JNEUROSCI.1395-14.2014","article-title":"Early adolescent MK-801 exposure impairs the maturation of ventral hippocampal control of basolateral amygdala drive in the adult prefrontal cortex","volume":"34","author":"Thomases","year":"2014","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0390","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1523\/JNEUROSCI.4147-12.2013","article-title":"Periadolescent exposure to the NMDA receptor antagonist MK-801 impairs the functional maturation of local GABAergic circuits in the adult prefrontal cortex","volume":"33","author":"Thomases","year":"2013","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0395","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbr.2012.01.057","article-title":"The NMDA receptor may participate in widespread suppression of circuit level neural activity, in addition to a similarly prominent role in circuit level activation","volume":"230","author":"Fitzgerald","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.bbr.2018.05.005_bib0400","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1176\/jnp.3.3.269","article-title":"Attention and higher cortical functions in schizophrenia","volume":"3","author":"Kenny","year":"1991","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0405","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2004.09.007","article-title":"Identification of separable cognitive factors in schizophrenia","volume":"72","author":"Nuechterlein","year":"2004","journal-title":"Schizophr Res."},{"issue":"1-3","key":"10.1016\/j.bbr.2018.05.005_bib0410","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.schres.2006.08.021","article-title":"A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects","volume":"89","author":"Woodward","year":"2007","journal-title":"Schizophr Res."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0415","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00228-013-1600-y","article-title":"Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis","volume":"70","author":"Desamericq","year":"2014","journal-title":"Eur J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0420","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbr.2008.05.016","article-title":"Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?","volume":"195","author":"Meltzer","year":"2008","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.bbr.2018.05.005_bib0425","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/acps.12374","article-title":"Second-generation antipsychotic effect on cognition in patients with schizophrenia--a meta-analysis of randomized clinical trials","volume":"131","author":"Nielsen","year":"2015","journal-title":"Acta Psychiatr Scand."},{"issue":"3","key":"10.1016\/j.bbr.2018.05.005_bib0430","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.neuropharm.2011.03.015","article-title":"NMDA receptors, cognition and schizophrenia--testing the validity of the NMDA receptor hypofunction hypothesis","volume":"62","author":"Gilmour","year":"2012","journal-title":"Neuropharmacology"},{"issue":"21\u201322","key":"10.1016\/j.bbr.2018.05.005_bib0435","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1007\/s00213-015-3954-6","article-title":"The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia","volume":"232","author":"Janhunen","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2018.05.005_bib0440","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1038\/tp.2015.21","article-title":"Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT\/GSK3beta pathway","volume":"5","author":"Wong","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbr.2018.05.005_bib0445","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1096\/fasebj.6.6.1347506","article-title":"Neuroactive steroids","volume":"6","author":"Paul","year":"1992","journal-title":"FASEB J."},{"issue":"1-3","key":"10.1016\/j.bbr.2018.05.005_bib0450","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0165-0173(01)00140-0","article-title":"Neuroactive steroids and peripheral myelin proteins","volume":"37","author":"Magnaghi","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0455","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pneurobio.2009.07.001","article-title":"Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance","volume":"89","author":"Zheng","year":"2009","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0460","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1124\/jpet.110.178244","article-title":"Inhibition of recombinant L-type voltage-gated calcium channels by positive allosteric modulators of GABAA receptors","volume":"337","author":"Earl","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0465","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(97)83020-8","article-title":"SA4503, a novel cognitive enhancer with sigma1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice","volume":"328","author":"Maurice","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0470","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0306-4522(97)00405-3","article-title":"Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism","volume":"83","author":"Maurice","year":"1998","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0475","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0006-8993(98)00469-7","article-title":"The modulation by neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma1 (sigma1) receptors","volume":"799","author":"Urani","year":"1998","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.bbr.2018.05.005_bib0480","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1124\/mol.65.5.1191","article-title":"Selective antagonism of 5alpha-reduced neurosteroid effects at GABA(A) receptors","volume":"65","author":"Mennerick","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"1-3","key":"10.1016\/j.bbr.2018.05.005_bib0485","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2006.07.039","article-title":"Neurosteroid modulation of recombinant rat alpha5beta2gamma2L and alpha1beta2gamma2L GABA(A) receptors in Xenopus oocyte","volume":"547","author":"Rahman","year":"2006","journal-title":"Eur J. Pharmacol."},{"key":"10.1016\/j.bbr.2018.05.005_bib0490","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0074-7742(01)46071-5","article-title":"Neuroactive steroids and central nervous system disorders","volume":"46","author":"Wang","year":"2001","journal-title":"Int. Rev. Neurobiol."},{"issue":"5","key":"10.1016\/j.bbr.2018.05.005_bib0495","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1523\/JNEUROSCI.22-05-01541.2002","article-title":"Enhanced neurosteroid potentiation of ternary GABA(a) receptors containing the delta subunit","volume":"22","author":"Wohlfarth","year":"2002","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2018.05.005_bib0500","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuropharm.2008.06.072","article-title":"Regulation of inhibitory synaptic transmission by a conserved atypical interaction of GABA(a) receptor beta- and gamma-subunits with the clathrin AP2 adaptor","volume":"55","author":"Smith","year":"2008","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.bbr.2018.05.005_bib0505","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.005_bib0510","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1124\/mol.64.4.857","article-title":"A presynaptic action of the neurosteroid pregnenolone sulfate on GABAergic synaptic transmission","volume":"64","author":"Mtchedlishvili","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.005_bib0515","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.bjp.0704543","article-title":"Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids","volume":"135","author":"Malayev","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbr.2018.05.005_bib0520","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0026-895X(25)12923-4","article-title":"Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor","volume":"40","author":"Wu","year":"1991","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0525","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pneurobio.2003.09.001","article-title":"Neurosteroid modulation of GABAA receptors","volume":"71","author":"Lambert","year":"2003","journal-title":"Prog. Neurobiol"},{"issue":"5","key":"10.1016\/j.bbr.2018.05.005_bib0530","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0896-6273(90)90202-Q","article-title":"Neurosteroids act on recombinant human GABAA receptors","volume":"4","author":"Puia","year":"1990","journal-title":"Neuron"},{"issue":"24","key":"10.1016\/j.bbr.2018.05.005_bib0535","doi-asserted-by":"crossref","first-page":"14439","DOI":"10.1073\/pnas.2435457100","article-title":"Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors","volume":"100","author":"Stell","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"10.1016\/j.bbr.2018.05.005_bib0540","doi-asserted-by":"crossref","first-page":"12905","DOI":"10.1073\/pnas.96.22.12905","article-title":"Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice","volume":"96","author":"Mihalek","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0545","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbrc.2008.05.055","article-title":"Neurosteroids allosterically modulate the ion pore of the NMDA receptor consisting of NR1\/NR2B but not NR1\/NR2A","volume":"372","author":"Elfverson","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0550","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/jpet.107.130518","article-title":"Molecular mechanisms for nanomolar concentrations of neurosteroids at NR1\/NR2B receptors","volume":"324","author":"Johansson","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0555","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1124\/mol.111.076141","article-title":"The novel antipsychotic drug lurasidone enhances N-methyl-D-aspartate receptor-mediated synaptic responses","volume":"81","author":"Yuen","year":"2012","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0560","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biopsych.2016.07.004","article-title":"Insights about striatal circuit function and schizophrenia from a mouse model of dopamine D2 receptor upregulation","volume":"81","author":"Simpson","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.bbr.2018.05.005_bib0565","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1046\/j.1460-9568.1999.00816.x","article-title":"The neurosteroid pregnenolone sulphate increases dopamine release and the dopaminergic response to morphine in the rat nucleus accumbens","volume":"11","author":"Barrot","year":"1999","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0570","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1460-9568.2002.02084.x","article-title":"The neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumbens","volume":"16","author":"Rouge-Pont","year":"2002","journal-title":"Eur. J. Neurosci."},{"issue":"12","key":"10.1016\/j.bbr.2018.05.005_bib0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051455","article-title":"Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0580","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2004.07.009","article-title":"Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism","volume":"1023","author":"Chung","year":"2004","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0585","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0022-3565(24)38019-X","article-title":"Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens","volume":"288","author":"Kuroki","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.bbr.2018.05.005_bib0590","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1177\/0269881117731278","article-title":"Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats","volume":"31","author":"Miyauchi","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.bbr.2018.05.005_bib0595","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/syn.20354","article-title":"Glutamate receptors in nucleus accumbens mediate regionally selective increases in cortical acetylcholine release","volume":"61","author":"Zmarowski","year":"2007","journal-title":"Synapse"},{"issue":"8","key":"10.1016\/j.bbr.2018.05.005_bib0600","doi-asserted-by":"crossref","first-page":"e2935","DOI":"10.1371\/journal.pone.0002935","article-title":"Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer\u2019s disease","volume":"3","author":"Rodriguez","year":"2008","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbr.2018.05.005_bib0605","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1515\/CCLM.2004.088","article-title":"Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer\u2019s disease and vascular dementia","volume":"42","author":"Bicikova","year":"2004","journal-title":"Clin. Chem. Lab Med."},{"issue":"3","key":"10.1016\/j.bbr.2018.05.005_bib0610","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/156720512800107591","article-title":"Neurosteroid PREGS protects neurite growth and survival of newborn neurons in the hippocampal dentate gyrus of APPswe\/PS1dE9 mice","volume":"9","author":"Xu","year":"2012","journal-title":"Curr. Alzheimer Res."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0615","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","article-title":"Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia","volume":"36","author":"Emamian","year":"2004","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0620","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pharmthera.2005.10.014","article-title":"The role of the phosphatidylinositide 3-kinase-protein kinase b pathway in schizophrenia","volume":"110","author":"Kalkman","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0625","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0924-977X(01)00131-6","article-title":"GSK-3 and the neurodevelopmental hypothesis of schizophrenia","volume":"12","author":"Kozlovsky","year":"2002","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.bbr.2018.05.005_bib0630","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/sj.npp.1301511","article-title":"The role of Akt-GSK-3beta signaling and synaptic strength in phencyclidine-induced neurodegeneration","volume":"33","author":"Lei","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"2-3","key":"10.1016\/j.bbr.2018.05.005_bib0635","first-page":"196","article-title":"Effect of novel antipsychotic drugs on phencyclidine-induced stereotyped behaviour and social isolation in the rat social interaction test","volume":"8","author":"Sams-Dodd","year":"1997","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2018.05.005_bib0640","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1515\/REVNEURO.1999.10.1.59","article-title":"Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity","volume":"10","author":"Sams-Dodd","year":"1999","journal-title":"Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0645","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bbr.2007.10.012","article-title":"Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats--a preliminary investigation","volume":"187","author":"Snigdha","year":"2008","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2018.05.005_bib0650","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/npp.2015.189","article-title":"Potentiation of M1 muscarinic receptor reverses plasticity deficits and negative and cognitive symptoms in a schizophrenia mouse model","volume":"41","author":"Ghoshal","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.bbr.2018.05.005_bib0655","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1177\/0269881114544778","article-title":"Analysis of sociability and preference for social novelty in the acute and subchronic phencyclidine rat","volume":"28","author":"McKibben","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2018.05.005_bib0660","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jsbmb.2012.08.009","article-title":"Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia","volume":"133","author":"Bicikova","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.bbr.2018.05.005_bib0665","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.euroneuro.2006.10.001","article-title":"Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects","volume":"17","author":"Ritsner","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.005_bib0670","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.pbb.2006.07.026","article-title":"Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy?","volume":"84","author":"Marx","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.bbr.2018.05.005_bib0675","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.pbb.2006.07.032","article-title":"Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions","volume":"84","author":"Marx","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.bbr.2018.05.005_bib0680","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/sj.npp.1300952","article-title":"Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics","volume":"31","author":"Marx","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"17","key":"10.1016\/j.bbr.2018.05.005_bib0685","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1007\/s00213-014-3673-4","article-title":"Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia","volume":"231","author":"Marx","year":"2014","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817320727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817320727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T18:36:03Z","timestamp":1751654163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432817320727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":137,"alternative-id":["S0166432817320727"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2018.05.005","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine-induced deficits in cognitive function and social interaction","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2018.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}